The efficacy of the Rességuier method in the treatment of fibromyalgia: a randomised controlled trial

Completed

• Conditions: Fibromyalgia; Musculoskeletal Diseases; Other soft tissue disorders, not elsewhere classified

• Registration Number: ISRCTN62054712
• Lead Sponsor: niversity of Florence (Italy)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2008-12-23
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 36

Inclusion Criteria

1. Diagnosis of fibromyalgia according to the American College of Rheumatology (ACR) criteria
2. No age limits

Exclusion Criteria

Does not meet the inclusion criteria

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. Reduction of pain (Numerical Rating Scale [NRS]: 0 - 10)<br>2. Improvement of disability and quality of life, assessed by the 36-item Short Form (SF-36) Health Survey and Fibromyalgia Impact Questionnaire (FIQ)

Secondary Outcome Measures

Name	Time	Method
1. Quality of movement (NRS: 0 - 10)<br>2. Ability to relax mind and body (NRS: 0 - 10)